Strata Critical Medical, Inc. (SRTA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-418.4%

-$13.63

vs $4.28 price

Levered DCF

-$12.61

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

4.59

Safe zone

Rating

A-

Overall 4 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	9.62×	-12.14×	-4.64×	-9.42×	-18.25×	-12.41×	-6.69×
P/B	1.42×	1.48×	1.11×	0.93×	2.5×	11.35×	14.47×
P/S	2.01×	1.32×	1.15×	1.75×	14.43×	5.37×	2.32×
EV / EBITDA	-64.63×	-14.83×	-5.08×	-10.4×	-16.87×	-11.74×	-6.46×
Gross margin	20.9%	23.7%	18.7%	15.2%	20.8%	9.9%	15.1%
Operating margin	-11.3%	-13.6%	-30.3%	-36.6%	-47.7%	-44.2%	-37.0%
Net margin	21.0%	-11.0%	-24.9%	-18.7%	-79.3%	-43.4%	-34.7%
Current ratio	6.38×	7.07×	5.81×	8.2×	23.07×	2.27×	3.85×
Debt / equity	0.01×	0.04×	0.1×	0.07×	0×	0.17×	0.09×
Interest coverage	0×	0×	0×	0×	0×	-10,359×	0×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	14.8%	-12.3%	-23.9%	-9.9%	-13.7%	-91.7%	-216.8%
Return on invested capital	-7.3%	-14.2%	-25.1%	-17.2%	-6.8%	-79.9%	-4.2%
Return on assets	12.7%	-10.6%	-19.0%	-8.4%	-11.9%	-57.4%	-3.9%
Free cash flow yield	-15.1%	-10.8%	-13.3%	-14.8%	-2.2%	-8.9%	-15.4%
Earnings yield	10.4%	-8.3%	-21.6%	-10.7%	-5.5%	-8.1%	-15.0%
Enterprise value	$368.9M	$320.3M	$256.2M	$232M	$727.1M	$115.5M	$71.5M
Net debt / EBITDA	4.85×	0.42×	0.07×	1.03×	0.04×	1.05×	0.08×
Cash conversion cycle (days)	29	32	34	-22	-13	12	0